These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32849284)

  • 1. Randomized Clinical Trial: Bergamot Citrus and Wild Cardoon Reduce Liver Steatosis and Body Weight in Non-diabetic Individuals Aged Over 50 Years.
    Ferro Y; Montalcini T; Mazza E; Foti D; Angotti E; Gliozzi M; Nucera S; Paone S; Bombardelli E; Aversa I; Musolino V; Mollace V; Pujia A
    Front Endocrinol (Lausanne); 2020; 11():494. PubMed ID: 32849284
    [No Abstract]   [Full Text] [Related]  

  • 2. Citrus Bergamia and Cynara Cardunculus Reduce Serum Uric Acid in Individuals with Non-Alcoholic Fatty Liver Disease.
    Ferro Y; Maurotti S; Mazza E; Pujia R; Sciacqua A; Musolino V; Mollace V; Pujia A; Montalcini T
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease.
    Ferro Y; Pujia R; Mazza E; Lascala L; Lodari O; Maurotti S; Pujia A; Montalcini T
    J Transl Med; 2022 Aug; 20(1):377. PubMed ID: 35986358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a herbal extract powder (YY-312) from Imperata cylindrica Beauvois, Citrus unshiu Markovich, and Evodia officinalis Dode on body fat mass in overweight adults: a 12-week, randomized, double-blind, placebo-controlled, parallel-group clinical trial.
    Cho YG; Jung JH; Kang JH; Kwon JS; Yu SP; Baik TG
    BMC Complement Altern Med; 2017 Jul; 17(1):375. PubMed ID: 28754119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artichoke and Bergamot Phytosome Alliance: A Randomized Double Blind Clinical Trial in Mild Hypercholesterolemia.
    Riva A; Petrangolini G; Allegrini P; Perna S; Giacosa A; Peroni G; Faliva MA; Naso M; Rondanelli M
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bergamot polyphenol fraction prevents nonalcoholic fatty liver disease via stimulation of lipophagy in cafeteria diet-induced rat model of metabolic syndrome.
    Parafati M; Lascala A; Morittu VM; Trimboli F; Rizzuto A; Brunelli E; Coscarelli F; Costa N; Britti D; Ehrlich J; Isidoro C; Mollace V; Janda E
    J Nutr Biochem; 2015 Sep; 26(9):938-48. PubMed ID: 26025327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Taheri H; Malek M; Ismail-Beigi F; Zamani F; Sohrabi M; Reza Babaei M; Khamseh ME
    Adv Ther; 2020 Nov; 37(11):4697-4708. PubMed ID: 32975679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Daesiho-tang on obesity with non-alcoholic fatty liver disease: a study protocol for a randomised, double-blind, placebo-controlled pilot trial.
    Han K; Kwon O; Park HJ; Jung SY; Yang C; Son CG
    Trials; 2020 Jan; 21(1):128. PubMed ID: 32005283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial.
    Loomba R; Morgan E; Watts L; Xia S; Hannan LA; Geary RS; Baker BF; Bhanot S
    Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):829-838. PubMed ID: 32553151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bergamot Polyphenols Boost Therapeutic Effects of the Diet on Non-Alcoholic Steatohepatitis (NASH) Induced by "Junk Food": Evidence for Anti-Inflammatory Activity.
    Parafati M; Lascala A; La Russa D; Mignogna C; Trimboli F; Morittu VM; Riillo C; Macirella R; Mollace V; Brunelli E; Janda E
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30388763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study.
    Oscarsson J; Önnerhag K; Risérus U; Sundén M; Johansson L; Jansson PA; Moris L; Nilsson PM; Eriksson JW; Lind L
    J Clin Lipidol; 2018; 12(6):1390-1403.e4. PubMed ID: 30197273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
    Daneshi-Maskooni M; Keshavarz SA; Qorbani M; Mansouri S; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    BMC Complement Altern Med; 2019 Mar; 19(1):59. PubMed ID: 30871514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study.
    Eriksson JW; Lundkvist P; Jansson PA; Johansson L; Kvarnström M; Moris L; Miliotis T; Forsberg GB; Risérus U; Lind L; Oscarsson J
    Diabetologia; 2018 Sep; 61(9):1923-1934. PubMed ID: 29971527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
    Daneshi-Maskooni M; Keshavarz SA; Mansouri S; Qorbani M; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    Trials; 2017 Jun; 18(1):260. PubMed ID: 28592311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of green coffee extract supplementation on serum adiponectin concentration and lipid profile in patients with non-alcoholic fatty liver disease: A randomized, controlled trial.
    Hosseinabadi S; Rafraf M; Asghari S; Asghari-Jafarabadi M; Vojouhi S
    Complement Ther Med; 2020 Mar; 49():102290. PubMed ID: 32147076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherogenic Index Reduction and Weight Loss in Metabolic Syndrome Patients Treated with A Novel Pectin-Enriched Formulation of Bergamot Polyphenols.
    Capomolla AS; Janda E; Paone S; Parafati M; Sawicki T; Mollace R; Ragusa S; Mollace V
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31167512
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial.
    Hosseinpour-Arjmand S; Amirkhizi F; Ebrahimi-Mameghani M
    J Clin Pharm Ther; 2019 Apr; 44(2):258-267. PubMed ID: 30585337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical study to assess the efficacy and safety of a citrus polyphenolic extract of red orange, grapefruit, and orange (Sinetrol-XPur) on weight management and metabolic parameters in healthy overweight individuals.
    Dallas C; Gerbi A; Elbez Y; Caillard P; Zamaria N; Cloarec M
    Phytother Res; 2014 Feb; 28(2):212-8. PubMed ID: 23554029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-arm, placebo-controlled, randomized clinical trial evaluating the metabolic effect of a combined nutraceutical containing a bergamot standardized flavonoid extract in dyslipidemic overweight subjects.
    Cicero AFG; Fogacci F; Bove M; Giovannini M; Borghi C
    Phytother Res; 2019 Aug; 33(8):2094-2101. PubMed ID: 31225673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of citrus polymethoxyflavones, green tea polyphenols, and Lychee extracts suppresses obesity and hepatic steatosis in high-fat diet induced obese mice.
    Pan MH; Yang G; Li S; Li MY; Tsai ML; Wu JC; Badmaev V; Ho CT; Lai CS
    Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28643888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.